生物标志物 生物标志物
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Gothenburg, Sweden.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
阿尔茨海默病 (AD) 显示SV2A PET信号的减少. 这项研究表明,减少的SV2A PET反映了突触损失,而不是剩余突触中的蛋白质减少,有助于神经退行性疾病的生物标志物的发展.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 生物标志物开发 生物标志物开发
背景情况:
- 在阿尔茨海默病 (AD) 大脑中通过PET观察到SV2A水平的降低.
- 不确定性存在于SV2A降低是否反映突触损失或蛋白质减少,影响AD治疗和生物标志物的解释.
- 这项研究调查了死后脑组织的突触和同质分数中的SV2A蛋白水平.
研究的目的:
- 区分突触损失和SV2A蛋白减少作为导致阿尔茨海默病SV2A PET信号减少的原因.
- 为了评估从死后人类脑组织中得到的突触丰富和原始同质分数中的SV2A蛋白水平.
- 为解释SV2A PET作为神经退行性疾病的生物标志物提供信息.
主要方法:
- 针对性质谱法用于死后的脑内皮层,小脑和中心半圆组织,来自对照和AD病例.
- 来自全同质和同质突神经元分量的蛋白质使用高流液体染色学和选择反应监测进行了量化.
- 测量了包括SV2A在内的31个突触相关蛋白质的面板,以评估蛋白质水平和相关性.
主要成果:
- 发现SV2A与总同质物相比,在突触神经元组分数中富含.
- SV2A水平与突触素和SNARE复合蛋白具有很强的相关性.
- 在对照组和AD组之间的synaptoneurosome分数中没有观察到SV2A蛋白水平的显著差异,但在AD总同质体中观察到下降的趋势.
结论:
- 在AD中SV2A PET信号的减少与突触的损失相一致,而不是剩余突触内的SV2A蛋白的减少.
- 这些发现有助于FNIH生物标志物联盟的SV2A PET项目,旨在了解AD中SV2A PET信号的生物变化.
- 这些结果支持使用SV2A PET作为反映神经退行性疾病中突触完整性的生物标志物.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516